Intersect ENT Appoints David Lehman General Counsel

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of David Lehman as general counsel. Mr. Lehman brings three decades of legal experience to Intersect ENT, most recently having served as general counsel and secretary for Thoratec Corporation (NASDAQ:THOR), a global leader in medical technology to address advanced-stage heart failure, where he saw the company through tremendous growth and eventual sale to St. Jude Medical.

Back to news